Gene delivery using helper virus-free HSV-1 amplicon vectors

Area of Science:

• Virology
• Molecular Biology
• Gene Therapy

Background:

• Herpes simplex virus type 1 (HSV-1)-based amplicon vectors are valuable tools in molecular biology and gene therapy.
• Their replication and packaging traditionally rely on helper functions from HSV-1 mutants or defective genomes, often leading to contamination.
• Developing methods for producing helper-virus-free amplicon stocks is crucial for safety and efficacy.

Purpose of the Study:

• To describe a novel method for generating herpes simplex virus type 1 (HSV-1)-based amplicon vectors free of contaminating helper virus.
• To establish a protocol for producing high-titer, pure amplicon stocks suitable for various applications.

Main Methods:

• Utilizing sets of overlapping cosmids to reconstitute replication-competent but packaging-defective HSV-1 genomes.
• Deleting DNA cleavage/packaging signals from reconstituted HSV-1 genomes to render them non-packageable.
• Cotransfecting amplicon DNA with the packaging-defective HSV-1 cosmid DNA into 2-2 cells.
• Harvesting packaged amplicon vector particles and determining their titers.

Main Results:

• Successfully generated infectious HSV-1 amplicon vectors.
• The resulting vector stocks were demonstrated to be free of contaminating helper virus.
• The described protocol provides a reliable method for producing pure amplicon preparations.

Conclusions:

• The developed method effectively produces helper-virus-free HSV-1 amplicon vectors.
• This advancement is significant for the safe and efficient application of HSV-1 amplicon technology in research and potentially in therapeutic settings.
• The protocol offers a robust strategy for generating high-quality amplicon stocks.